JOHN A. LOWE III;M. AMIN KHAN;APTINYX INC.;NAUREX INC.
发明人:
JOHN A. LOWE III,M. AMIN KHAN
申请号：
IL24016315
公开号：
IL240163A
申请日:
2015.07.27
申请国别(地区):
IL
年份:
2020
代理人:
摘要：
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
